West Pharmaceutical Services | WST - Operating Expenses

Stock Price
250.49
Daily Change
6.88 2.82%
Monthly
-8.91%
Yearly
16.65%
Q1 Forecast
241.31

West Pharmaceutical Services reported $642.5M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Align Technology USD 822.85M 11.8M Dec/2025
Avanos Medical USD 158.83M 69.83M Sep/2025
Baxter International USD 3.19B 554.4M Dec/2025
Becton, Dickinson and Co. USD 4.59B 476M Dec/2025
Cerus USD 34.78M 2.98M Dec/2024
Charles River Laboratories USD 3.41B 2.51B Sep/2025
Cooper Companies USD 924.8M 40.2M Sep/2025
Dentsply International USD 1.48B 653M Sep/2025
Haemonetics USD 134.99M 1.26M Dec/2025
ICU Medical USD 510.13M 11.93M Sep/2025
Insulet USD 588.6M 60.6M Sep/2025
Integra LifeSciences USD 1.04B 620.66M Sep/2025
IQVIA Holdings USD 1.69B 4.47B Dec/2025
J&J USD 18.97B 2.38B Dec/2025
Medtronic USD 7.26B 283M Sep/2025
Merit Medical Systems USD 341.54M 6.11M Sep/2025
Neogen USD 230.07M 4.79M Sep/2025
OraSure Technologies USD 23.07M 4.36M Sep/2024
Quidel USD 760.9M 1.28B Dec/2025
Repligen USD 176.13M 279K Sep/2025
Rockwell Medical USD 30.41M 1.11M Jun/2025
Solventum Corp USD 4.99B 3.04B Sep/2025
STAAR Surgical USD 69.04M 8.29M Jun/2025
Terumo JPY 252.74B 22.88B Dec/2025
Utah Medical Products USD 6.25M 80K Sep/2024
West Pharmaceutical Services USD 642.5M 2.41B Dec/2025